Daly Jason B.'s Form 4 filing
Amneal Pharmaceuticals, Inc. (AMRX) · filed Mar 7, 2025
- Accession no.
- 0001628280-25-011306
- Filed
- Mar 7, 2025
- Trade date
- Mar 5-6, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $792.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Daly Jason B.CIK 0001906486 | Officer (EVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 5, 2025 | Class A Common Stock | SSaleDisposed | −43,064 | $8.88 | −$382,408.32 | 79,542 | Direct | |
| Mar 6, 2025 | Class A Common Stock | SSaleDisposed | −46,936 | $8.73 | −$409,751.28 | 32,606 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.